CEO Robert Parkinson

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX) announced today that the company has completed its planned acquisition of Synovis Life Technologies, Inc. (NASDAQ: SYNO), following approval of the transaction by Synovis shareholders. The acquisition expands Baxters regenerative medicine and BioSurgery franchise by adding biological and mechanical products from Synovis used for...  

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE: BAX) announced today that it will present at the Citi 2012 Global Healthcare Conference on Wednesday, February 29, 2012, at 10:00 a.m. (ET). The live webcast of Baxter’s presentation can be accessed from the Baxter corporate website at www.baxter.com and will be available for replay through March 29, 2012. Baxter International Inc. develops, manufactures and markets products...  

(Reuters) — Baxter International Inc. reported a higher quarterly profit on Thursday, helped by sales of its products for hemophilia and immune disorders, but the company issued a 2012 forecast below Wall Street's target.  

To get a clearer understanding of a company's ability to earn money and reward you, the shareholder, it's often better to focus on cash flow. In this series, we tear apart a company's cash flow statement to see how much money is truly being ...  

DEERFIELD, Ill. & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX) and Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA) today announced that they have entered into a global collaboration to develop and commercialize follow-on biologic products, also known as biosimilars. Biosimilars replicate existing, branded biologics used in the treatment of a variety of diseases including cancer...